Software Commercialisation Director appointment

RNS Number : 1463Y
Frontier IP Group plc
07 September 2020
 

RNS REACH

AIM: FIPP

07 September 2020

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Frontier IP Group appoints former Bango plc Senior Vice President as Software Commercialisation Director

 

 

Frontier IP, a specialist in commercialising intellectual property, is delighted to announce the appointment of Mark Rosten, the former Senior Vice President Development for mobile payments specialist Bango plc ("Bango" or the "Company"), as Software Commercialisation Director, a non-board role.

Mark has more than 30 years' experience in leading software and product development teams across Healthcare, FinTech and Transport, in companies ranging from start-ups to Small and Medium-Sized Enterprises and larger corporations.

As Senior Vice President Development at Bango, Mark led delivery of its largest product innovation project.  This provided direct carrier billing for the world's largest online e-commerce merchant with the leading Japanese telecom operators.

Mark's former leadership roles include EU Director of Product Development at GHX Europe where he designed and implemented a leading e-commerce platform in Healthcare for connecting hospitals across the United Kingdom with global medical device and pharmaceutical suppliers, automating ordering and invoicing, bringing significant savings and efficiencies, resulting in better care for patients.

For Frontier IP, Mark will be identifying opportunities and driving forward software development and projects across the portfolio and for the Group.

Neil Crabb, Frontier IP Group Chief Executive Officer, said: " We are very happy that someone of Mark's experience and calibre should be joining the Group. His appointment strengthens our capability to commercialise software-based opportunities, which are an increasingly important part of the portfolio."

Mark Rosten, Software Commercialisation Director, Frontier IP Group, said: "I am delighted to join Frontier IP and have a unique opportunity to work across a fantastic portfolio of companies. They have truly innovative ideas, making successful products that provide significant commercialisation opportunities across a range of industries."

 

 

 

 

 

 

 

ENQUIRIES

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

T: 0203 328 5656

Nick Athanas / James Hornigold

 

 

 

 

 

 

 

 

 

 

ABout frontier IP Group

Frontier IP unites science, finance and industry to build businesses based on outstanding research.  It identifies strong intellectual property and accelerates its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

About RNS Reach announcements

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain.  Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.
 
END
 
 
NRAFLFEVALIEIII
UK 100

Latest directors dealings